Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 18, 2026 3.878
November 17, 2026 3.878
November 16, 2026 3.878
November 13, 2026 3.878
November 12, 2026 3.878
November 11, 2026 3.878
November 10, 2026 3.878
November 09, 2026 3.878
November 06, 2026 3.878
November 05, 2026 3.878
November 04, 2026 3.878
November 03, 2026 3.878
November 02, 2026 3.878
October 30, 2026 3.878
October 29, 2026 3.878
October 28, 2026 3.878
October 27, 2026 3.878
October 26, 2026 3.878
October 23, 2026 3.878
October 22, 2026 3.878
October 21, 2026 3.878
October 20, 2026 3.878
October 19, 2026 3.878
October 16, 2026 3.878
October 15, 2026 3.878
Date Value
October 14, 2026 3.878
October 13, 2026 3.878
October 12, 2026 3.878
October 09, 2026 3.878
October 08, 2026 3.878
October 07, 2026 3.878
October 06, 2026 3.878
October 05, 2026 3.878
October 02, 2026 3.878
October 01, 2026 3.878
September 30, 2026 3.878
September 29, 2026 4.289
September 28, 2026 4.289
September 25, 2026 4.289
September 24, 2026 4.289
September 23, 2026 4.289
September 22, 2026 4.289
September 21, 2026 4.289
September 18, 2026 4.289
September 17, 2026 4.289
September 16, 2026 4.289
September 15, 2026 4.289
September 14, 2026 4.289
September 11, 2026 4.289
September 10, 2026 4.289

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Almirall SA 1.124
AstraZeneca PLC 11.71
ANI Pharmaceuticals, Inc. 2.569
Corcept Therapeutics, Inc. 8.892
Veru, Inc. 1.388

Price to Book Value Related Metrics